TrialJournal of translational medicine2025

Levilactobacillus brevis CD2 as a multifaceted probiotic to preserve oral health: results of a double-blind, randomized, placebo-controlled trial in healthy adults.

Serena Altamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.